Difference between revisions of "Angiocidin"
m |
m |
||
| Line 43: | Line 43: | ||
| Notes | | Notes | ||
| Cross-linked angiocidin disrupts the tumor ECM making it less permissive for tumor growth. | | Cross-linked angiocidin disrupts the tumor ECM making it less permissive for tumor growth. | ||
| − | + | Angiocidin inhibits tTgase-dependent incorporation of fibronectin into the ECM. | |
|- | |- | ||
| {{infobox header}} | | | {{infobox header}} | | ||
Revision as of 10:25, 23 September 2011
| Template:Infobox header| Angiocidin | |
|---|---|
| Substrate peptide name | Angiocidin |
| Synonyms | 26S proteasome non-ATPase regulatory subunit 4 |
| Determination type | In situ |
| Source | Homo sapiens (HUVEC) |
| Subcellular localization | Cytosol/Extracellular matrix |
| Swissprot ID | P55036 |
| Reactive glutamines | Not determined yet |
| Reactive lysines | - |
| Substrate sequence | Not determined yet |
| Structure | 2KDF |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:19931242 |
| Notes | Cross-linked angiocidin disrupts the tumor ECM making it less permissive for tumor growth.
Angiocidin inhibits tTgase-dependent incorporation of fibronectin into the ECM. |
| Template:Infobox header | |
